BioAtla (BCAB) Short Interest Ratio & Short Volume $0.41 -0.04 (-9.03%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$0.42 +0.01 (+3.16%) As of 02/21/2025 06:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends BioAtla Short Interest DataBioAtla (BCAB) has a short interest of 4.38 million shares. This marks a -13.44% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.9, indicating that it would take 3.9 days of the average trading volume of 789,264 shares to cover all short positions.Current Short Interest4,380,000 sharesPrevious Short Interest5,060,000 sharesChange Vs. Previous Month-13.44%Dollar Volume Sold Short$2.06 millionShort Interest Ratio3.9 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares48,350,000 sharesPercentage of Shares Shorted9.06%Today's Trading Volume891,845 sharesAverage Trading Volume789,264 sharesToday's Volume Vs. Average113% Short Selling BioAtla? Sign up to receive the latest short interest report for BioAtla and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBCAB Short Interest Over TimeBCAB Days to Cover Over TimeBCAB Percentage of Float Shorted Over Time BioAtla Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/20254,380,000 shares $2.06 million -13.4%N/A3.9 $0.47 1/15/20255,060,000 shares $2.44 million +15.0%N/A4.6 $0.48 12/31/20244,400,000 shares $2.60 million +11.4%N/A3.9 $0.59 12/15/20243,950,000 shares $5.73 million -0.8%N/A3 $1.45 11/30/20243,980,000 shares $6.69 million -3.9%N/A3.4 $1.68 11/15/20244,140,000 shares $6.46 million -15.0%N/A3.5 $1.56 10/31/20244,870,000 shares $9.35 million -7.1%N/A4 $1.92 10/15/20245,240,000 shares $10.22 million +17.2%N/A4.4 $1.95 9/30/20244,470,000 shares $7.87 million +0.5%N/A3.8 $1.76 9/15/20244,450,000 shares $8.05 million No ChangeN/A4.9 $1.81 Get the Latest News and Ratings for BCAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioAtla and its competitors with MarketBeat's FREE daily newsletter. 8/31/20244,450,000 shares $7.88 million -6.3%N/A5 $1.77 8/15/20244,750,000 shares $8.93 million +18.8%N/A5 $1.88 7/31/20244,000,000 shares $7.24 million +0.5%N/A4.7 $1.81 7/15/20243,980,000 shares $6.97 million -24.2%N/A4.5 $1.75 6/30/20245,250,000 shares $7.19 million -3.3%N/A6.4 $1.37 6/15/20245,430,000 shares $8.63 million +0.6%N/A7 $1.59 5/31/20245,400,000 shares $8.15 million +3.9%N/A7.1 $1.51 5/15/20245,200,000 shares $15.60 million -2.4%N/A7.4 $3.00 4/30/20245,330,000 shares $12.02 million -1.7%N/A8.8 $2.26 4/15/20245,420,000 shares $15.50 million -3.0%N/A10.1 $2.86 3/31/20245,590,000 shares $19.23 million +9.0%N/A10.9 $3.44 3/15/20245,130,000 shares $12.52 million +0.4%N/A11.6 $2.44 2/29/20245,110,000 shares $13.80 million +1.4%N/A11 $2.70 2/15/20245,040,000 shares $13.36 million +6.6%N/A9.6 $2.65 1/31/20244,730,000 shares $9.06 million -3.3%N/A9.5 $1.92 1/15/20244,890,000 shares $11.78 million +4.7%N/A9.5 $2.41 12/31/20234,670,000 shares $11.49 million +4.7%N/A9.5 $2.46 12/15/20234,460,000 shares $9.41 million +0.2%N/A9.6 $2.11 11/30/20234,450,000 shares $7.88 million +8.0%N/A10.9 $1.77 11/15/20234,120,000 shares $6.63 million +1.0%N/A12.1 $1.61 10/31/20234,080,000 shares $6.00 million -7.3%N/A13.9 $1.47 10/15/20234,400,000 shares $7.26 million -5.2%N/A17.5 $1.65 9/30/20234,640,000 shares $7.89 million -6.8%N/A20.1 $1.70 9/15/20234,980,000 shares $10.36 million +2.1%N/A20.7 $2.08 8/31/20234,880,000 shares $12.25 million +3.2%N/A13.6 $2.51 8/15/20234,730,000 shares $12.91 million +1.9%N/A12.1 $2.73 7/31/20234,640,000 shares $13.87 million -1.1%N/A11.1 $2.99 7/15/20234,690,000 shares $12.66 million +1.5%N/A10.7 $2.70 6/30/20234,620,000 shares $13.86 million +25.9%N/A8.7 $3.00 6/15/20233,670,000 shares $13.73 million +1.7%N/A6.1 $3.74Elon Takes Aim at Social Security (Ad)Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social Security, finding what he says is widespread fraud across the agency.>>Here are the NINE stocks everyone will wish they own once Elon moves.<< 5/31/20233,610,000 shares $11.37 million +0.6%N/A7.3 $3.15 5/15/20233,590,000 shares $13.89 million -5.0%N/A7.2 $3.87 4/30/20233,780,000 shares $12.74 million +16.7%N/A7.4 $3.37 4/15/20233,240,000 shares $11.66 million -10.3%N/A5.7 $3.60 3/31/20233,610,000 shares $9.67 million +10.4%N/A4.5 $2.68 3/15/20233,270,000 shares $8.37 million -0.6%N/A4.6 $2.56 2/28/20233,290,000 shares $9.80 million +13.8%N/A4.8 $2.98 2/15/20232,890,000 shares $9.88 million -0.3%N/A4.3 $3.42 1/31/20232,900,000 shares $10.99 million -10.8%N/A3.3 $3.79 1/15/20233,250,000 shares $11.25 million -21.9%N/A3.7 $3.46 12/30/20224,160,000 shares $34.32 million +2.2%N/A6.4 $8.25 12/15/20224,070,000 shares $36.51 million -5.1%N/A7.5 $8.97 11/30/20224,290,000 shares $47.23 million -3.6%N/A7.7 $11.01 11/15/20224,450,000 shares $39.16 million +10.2%N/A8 $8.80 10/31/20224,040,000 shares $27.84 million -20.6%N/A3.5 $6.89 10/15/20225,090,000 shares $35.07 million -1.0%N/A5.4 $6.89 9/30/20225,140,000 shares $39.58 million +27.5%N/A5.2 $7.70 9/15/20224,030,000 shares $34.46 million +7.8%N/A3.7 $8.55 8/31/20223,740,000 shares $32.58 million -32.9%N/A3.6 $8.71 8/15/20225,570,000 shares $44.56 million +27.2%N/A5.2 $8.00 7/31/20224,380,000 shares $14.89 million -9.5%N/A7.7 $3.40 7/15/20224,840,000 shares $20.38 million +19.5%N/A7.9 $4.21 6/30/20224,050,000 shares $11.54 million +2.3%N/A6.5 $2.85 6/15/20223,960,000 shares $10.49 million -1.5%N/A5.8 $2.65 5/31/20224,020,000 shares $9.69 million +2.6%N/A5.5 $2.41 5/15/20223,920,000 shares $9.02 million +1.8%N/A5.3 $2.30 4/30/20223,850,000 shares $13.40 million +5.8%N/A5.2 $3.48 4/15/20223,640,000 shares $14.56 million +1.7%N/A5.1 $4.00 3/31/20223,580,000 shares $17.90 million -5.0%N/A5 $5.00 3/15/20223,770,000 shares $18.93 million -4.8%N/A6.2 $5.02 2/28/20223,960,000 shares $25.66 million -6.2%N/A7.8 $6.48 2/15/20224,220,000 shares $29.58 million +6.6%N/A8.8 $7.01 1/31/20223,960,000 shares $37.86 million +12.8%N/A9.6 $9.56 1/15/20223,510,000 shares $44.33 million +9.0%N/A10.5 $12.63 12/31/20213,220,000 shares $63.21 million +4.2%N/A12.7 $19.63 12/15/20213,090,000 shares $65.11 million +16.2%N/A15.1 $21.07 11/30/20212,660,000 shares $67.17 million +10.4%N/A11.7 $25.25 11/15/20212,410,000 shares $65.50 million -13.9%N/A10.8 $27.18 10/29/20212,800,000 shares $81.84 million No ChangeN/A12.5 $29.23 10/15/20212,800,000 shares $79.38 million -3.5%N/A11.9 $28.35 9/30/20212,900,000 shares $85.38 million +7.0%N/A12.4 $29.44 9/15/20212,710,000 shares $99.89 million -6.6%N/A11.3 $36.86 8/31/20212,900,000 shares $119.16 million -2.4%N/A11.3 $41.09 8/13/20212,970,000 shares $122.39 million -7.5%N/A13.6 $41.21 7/30/20213,210,000 shares $131.58 million -3.3%N/A15.4 $40.99 7/15/20213,320,000 shares $125.46 million +0.6%N/A17 $37.79 6/30/20213,300,000 shares $139.85 million +11.1%N/A16.6 $42.38 6/15/20212,970,000 shares $117.73 million +8.8%N/A15.8 $39.64 5/28/20212,730,000 shares $117.53 million +1.5%N/A14.1 $43.05 5/14/20212,690,000 shares $122.61 million +13.5%12.8%11.4 $45.58Elon Takes Aim at Social Security (Ad)Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social Security, finding what he says is widespread fraud across the agency.>>Here are the NINE stocks everyone will wish they own once Elon moves.<< 4/30/20212,370,000 shares $121.37 million +2.2%11.2%9.4 $51.21 4/15/20212,320,000 shares $106.81 million +11.5%12.9%8.8 $46.04 3/31/20212,080,000 shares $104.73 million +54.1%11.5%7.4 $50.35 3/15/20211,350,000 shares $89.65 million +63.6%7.5%4.6 $66.41 2/26/2021825,000 shares $44.57 million +28.2%4.6%2.5 $54.03 2/12/2021643,700 shares $34.24 million +641.6%3.6%2 $53.19 1/29/202186,800 shares $3.77 million +76.4%0.5%0.2 $43.47 1/15/202149,200 shares $2.29 million No Change0.3%0.1 $46.52 BCAB Short Interest - Frequently Asked Questions What is BioAtla's current short interest? Short interest is the volume of BioAtla shares that have been sold short but have not yet been closed out or covered. As of January 31st, traders have sold 4,380,000 shares of BCAB short. Learn More on BioAtla's current short interest. What is a good short interest ratio for BioAtla? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BCAB shares currently have a short interest ratio of 4.0. Learn More on BioAtla's short interest ratio. Which institutional investors are shorting BioAtla? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of BioAtla: Group One Trading LLC, Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is BioAtla's short interest increasing or decreasing? BioAtla saw a decline in short interest during the month of January. As of January 31st, there was short interest totaling 4,380,000 shares, a decline of 13.4% from the previous total of 5,060,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does BioAtla's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to BioAtla: Galectin Therapeutics Inc. (18.48%), Inozyme Pharma, Inc. (8.33%), Acumen Pharmaceuticals, Inc. (4.19%), Entera Bio Ltd. (0.18%), X4 Pharmaceuticals, Inc. (9.74%), Cellectis S.A. (0.40%), Scilex Holding (2.42%), Protara Therapeutics, Inc. (20.36%), IGM Biosciences, Inc. (5.45%), Aligos Therapeutics, Inc. (21.83%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short BioAtla stock? Short selling BCAB is an investing strategy that aims to generate trading profit from BioAtla as its price is falling. BCAB shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BioAtla? A short squeeze for BioAtla occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BCAB, which in turn drives the price of the stock up even further. How often is BioAtla's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BCAB, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies Galectin Therapeutics Short Interest Inozyme Pharma Short Interest Acumen Pharmaceuticals Short Interest Entera Bio Short Interest X4 Pharmaceuticals Short Interest Cellectis Short Interest Scilex Short Interest Protara Therapeutics Short Interest IGM Biosciences Short Interest Aligos Therapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BCAB) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredEx-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. ...Colonial Metals | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored$5,000 DOGE check?Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a porti...Altimetry | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioAtla, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioAtla With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
